Uterine Leiomyomas
11
1
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (11)
Bleeding Control Methods in Open Myomectomy
The Learning Curve of a Gynecology and Obstetrics Resident Performing Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) Hysterectomy in a University Hospital
Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study
Symphion® System In-Office Study
The Effect of Anesthetic Technique on VEGF-C and PGE2
Fibroid Growth Study
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
Biologic Predictors of Leiomyoma Treatment Outcomes
Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization
Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner
Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids